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Antithrombin III During Liver Transplantation 
J.H. Lewis, FA Bontempo, M.V. Ragni, and T.E. Starzl 
A;\jTITHRO\1BI~ III (AT-III) is a liver-synthesized plasma glycoprotein of moderate size (58 kD) that can 
inhibit most of the activated serine proteases involved in 
coagulation (eg. thrombin. activated factor X. VII. etc). The 
inactivation involves formation of an irreversible complex. 
probably filtered from the circulation of the RES. The 
complex formation is a time-dependent reaction requiring 
minutes for maximum effect. In the presence of heparin. this 
reaction occurs immediately. The biologic half-life of AT-Ill 
has not been precisely determined but is estimated at 3 to 4 
days in a patient with congenital deficiency. Congenital 
AT·III deficiency (0.40 to 0.60 U/mL) is an uncommon 
disorder leading to arterial or venous thrombosis and embo-
lism in young adults. Acquired AT-lII deficiency is much 
more common. In parenchymal liver cell disease. AT·III is 
markedly decreased .because of lack of synthesis. It is also 
decreased. and may reach very low values, in the presence of 
disseminated intravascular coagulation (DIC). 
MATERIALS AND METHODS 
The electrophoretic immunodiffusion (EID) method with a polyval-
ent antibody (rabbit. Behring Diagnostics) was used. Well-defined 
rockets were formed and found to be proportional in height to 
antigen con..:entration. The range of AT-III levels in 104 normal 
subjects 11035 0.73 to 1.20 t..:/mL. 
For these studies. the tests were performed on frozen plasma 
samples left over from coagulation tests ordered for patient care. 
There "ere eight '-imrles from each of 15 patients: the time schedule 
of sampling is sheW, n in Figs I and 2. Seven patients had post necrotic 
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Fig 1. Antithrombin 11\ ievel during liver transplantation. 
Solid circles represent mean values of ail patients and solid 
squares represent four patients with rapid Iysis_ Blood sam-
ples were taken after Induction of anestheSia, 30 minutes 
before the anhepatlc stage. 10 minutes Into the anhepatic: 
stage,S minutes before reperfuslon, 5 minutes, 30 minutes, 
120 minutes after reperfuslon. and at the end of surgery. 
cirrhosis (PNC). four had primary biliary cirrhOSIS (PBC). and four 
had ,clerosing chl)langitis (SC I 
RESULTS 
Fig 1 plots the mean value for the entire group of patients at 
each time period. Data were replotted from four patients 
(three with P;'I.jC, one with SC) identified as "rapid Iysers": 
at some time during surgery each had a euglobulin lysis time 
of 15 minutes or less. The baseline for this group is lower 
than that for the whole group. 
Fig 2 shows the mean values for each diagnostic category. 
As expected, the mean baseline level in patients with PNC 
(0.39 U/mL) is much lower than those with PBC (0.82 
U/mL) or SC (0.77 U/mL). The latter two groups show 
decreasing AT-III levels during transplantation, whereas 
those in the PNC group actually increase. 
DISCUSSION 
These findings confirm the previous observation that base-
line levels of AT·II1 are low in patients with PNC. In PBC 
and SC, which may be life-threatening without major paren-
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Fig 2. Antithrombin ill 'evels In three groups of patients 
during liver transplantation. Open circles indicate patients 
with primary biliary Cirrhosis (4), solid squares sclerosing 
cholangitis (4), and closed circles postnecrotic cirrhosis (7). 
Blood samples were taken at the same time as those In Fig 1. 
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chymal cell involvement. the mean baseline values are nor-
mal or near normal. During the anhepatic period. no synthe-
sis can take place. Factors with short half-lives decrease 
significantly. On the other hand. the AT -III curves for the 
entire group of patients. as well as those for the rapid Iysers. 
are remarkably flat. AT-III level fluctuates very little pre-
sumably because its half-life is relatively long. and a :! hour 
period of nonproduction would not be expected to have any 
effect. The smaller numbers in each group and large stan-
dard error of the mean contribute to the lack of statistical 
LEWIS. BONTEMPO. RAGNI ET AL 
significance. However. these findings do not indicate the 
presence of any active process such as DIC. which is known 
to reduce AT-III levels significantly. During the entire 
operation and particularly in early stage 111 (neohepatic 
stage). patients receive large amounts of blood. This replace-
ment appears to correct to some degree the defect in AT-III 
levels of PNC patients. 
In summary. AT-III appears not to be involved in any 
active process during liver transplantation. suggesting that 
DIC is not a major complication of this surgery. 
